Publication:
A new approach to vocal cord leukoplakia and evaluation of proton pump ınhibitor treatment.

Simple item page
dc.contributor.authorOzturan, ORHAN
dc.contributor.authorSezen, Goktas
dc.contributor.authorÇALıM, ÖMER FARUK
dc.contributor.authorYENIGUN, A
dc.contributor.authorDOGAN, REMZİ
dc.contributor.authorTUGRUL, SELHATTİN
dc.contributor.institutionauthorDOĞAN, REMZI
dc.contributor.institutionauthorYENİGÜN, ALPER
dc.contributor.institutionauthorÇALIM, ÖMER FARUK
dc.contributor.institutionauthorÖZTURAN, ORHAN
dc.contributor.institutionauthorTUĞRUL, SELAHATTİN
dc.date.accessioned2019-10-05T12:39:34Z
dc.date.available2019-10-05T12:39:34Z
dc.date.issued2019-02-01
dc.description.abstractPurpose: Our aim is identify a new approach to vocal cord leukoplakia treatment and detect to efficiency of proton pump inhibitors. Study design: Prospective, nonrandomized experimental clinical trial. Methods: A 'First Assessment Scale' was prepared. This scale included the lesion's and the patient's characteristics. Using this scale, 24 patients included to the study. 20 mg rabeprazole twice daily was applied to all patients. At the end of 3rd month, a 'Second Assessment Scale' was used and two groups created. In group 1, 19 patients were accepted to responsive for the therapy and received the same therapy. The group 2 was included five patients that accepted unresponsive to treatment and directed to surgery. All patients received the same treatment additionally 3 months. At the end of 6th month, the Reflux Symptom Index (RSI), the Reflux Finding Score (RFS) and the Red-Green-Blue (RGB) values evaluated and comparisons were made. Results: The RSI and RFS values were significantly decreased in all patients. The Red values were significantly decreased with treatment in group 1, but the Green and Blue values were not. In group 2, the RGB values were not showed the significant differences. In conclusion, seven patients (29,2%) showed complete lesion regression, 12 patients (50%) showed partial lesion regression and five patients (20,8%) showed no response to treatment. Conclusions: The proton pump inhibitor treatment may be beneficial for the selected patients. The scales that we prepared were useful for lesion assesment.en
dc.identifier
dc.identifier.citationSezen G., DOGAN R., YENIGUN A., ÇALıM Ö. F. , Ozturan O., TUGRUL S., -A new approach to vocal cord leukoplakia and evaluation of proton pump ınhibitor treatment.-, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, cilt.276, ss.467-471, 2019
dc.identifier.pubmed30607560
dc.identifier.urihttps://hdl.handle.net/20.500.12645/296
dc.language.isoen
dc.titleA new approach to vocal cord leukoplakia and evaluation of proton pump ınhibitor treatment.
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameAtatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi
local.avesis.id03f70a25-cabe-49bf-9c77-69266a91769d
local.avesis.response166
local.org.facultyTıp Fakültesi
relation.isAuthorOfPublication24246249-6961-4f71-8382-1bf0f01b3c78
relation.isAuthorOfPublicatione9d3c6c5-8d8a-4267-a9ff-0c87df962a63
relation.isAuthorOfPublication07d9f94f-4845-4056-b486-ad19c15144cd
relation.isAuthorOfPublicationb6584c26-ac5f-477f-aff0-4959fb8b3f99
relation.isAuthorOfPublicationbe6f07ba-a8f6-424a-84d8-5fa8c8df68c5
relation.isAuthorOfPublication.latestForDiscovery24246249-6961-4f71-8382-1bf0f01b3c78
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
A new approach to vocal cord leukoplakia and evaluation of proton pump ınhibitor treatment.pdf
Size:
748.51 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Yayınlar - Eserler
Tıp Fakültesi